SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-17-006843
Filing Date
2017-11-09
Accepted
2017-11-09 16:45:29
Documents
76
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_110917p.htm 10-Q 905311
2 EXHIBIT 10.4 exh_104.htm EX-10.4 453
3 EXHIBIT 31.1 exh_311.htm EX-31.1 6529
4 EXHIBIT 31.2 exh_312.htm EX-31.2 6530
5 EXHIBIT 32.1 exh_321.htm EX-32.1 3520
12 GRAPHIC exh104_01.jpg GRAPHIC 239766
  Complete submission text file 0001171843-17-006843.txt   6326138

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE args-20170930.xml EX-101.INS 953490
7 XBRL SCHEMA FILE args-20170930.xsd EX-101.SCH 77206
8 XBRL CALCULATION FILE args-20170930_cal.xml EX-101.CAL 29515
9 XBRL DEFINITION FILE args-20170930_def.xml EX-101.DEF 606292
10 XBRL LABEL FILE args-20170930_lab.xml EX-101.LAB 443493
11 XBRL PRESENTATION FILE args-20170930_pre.xml EX-101.PRE 614683
Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Filer) CIK: 0001105533 (see all company filings)

IRS No.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35443 | Film No.: 171191500
SIC: 2834 Pharmaceutical Preparations